Hikma Pharmaceuticals PLC (LON:HIK)
London
· Delayed Price · Currency is GBP · Price in GBp 1,648.20
+4.20 (0.26%)
Sep 29, 2025, 10:43 AM BST
Hikma Pharmaceuticals Market Cap
Hikma Pharmaceuticals has a market cap or net worth of 3.64 billion as of September 29, 2025. Its market cap has decreased by -15.93% in one year.
Market Cap
3.64B
Enterprise Value
4.62B
Revenue
2.35B
Ranking
n/a
PE Ratio
13.50
Stock Price
1,648.20
Market Cap Chart
Since November 2, 2005, Hikma Pharmaceuticals's market cap has increased from 469.64M to 3.64B, an increase of 675.21%. That is a compound annual growth rate of 10.83%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 170.58B |
| GSK plc | 59.81B |
| Haleon | 29.41B |
| Smith & Nephew | 11.42B |
| ConvaTec Group | 4.54B |
| HUTCHMED (China) | 1.98B |
| Genus | 1.52B |
| Oxford Nanopore Technologies | 1.44B |